Diagnosis and management of gestational trophoblastic neoplasia

Bailliere's Best Practice and Research in Clinical Obstetrics and Gynaecology

Volumn 17, Issue 6, 2003, Pages 893-903

  Ng, T Y ^a   Wong, L C ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Chemotherapy; Choriocarcinoma; Gestational trophoblastic neoplasia

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CACTINOMYCIN; CHORIONIC GONADOTROPIN; ETOPOSIDE; FLUOROURACIL; FOLINIC ACID; METHOTREXATE;

CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CHORIOCARCINOMA; CONTRACEPTION; DIAGNOSTIC TEST; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG TOXICITY; DRUG WITHDRAWAL; FOLLOW UP; GONADOTROPIN BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; HYSTERECTOMY; METASTASIS; MONOTHERAPY; PATHOLOGY; PREGNANCY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK ASSESSMENT; SALPINGOOOPHORECTOMY; TROPHOBLASTIC TUMOR;

EID: 0346392788     PISSN: 15216934     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1521-6934(03)00098-1     Document Type: Review

References (21)

1. When to start chemotherapy for persistent mole and when to stop. In Cole LA (ed.) Trophoblast Disease Update, Vol. 1.; 1996. Retrieved 24/1/03 from International Society for the Study of Trophoblastic Diseases website: http://www.isstd.org/journal/vol1.html.
2. Ngan HYS, Benedet JL, Bender HG et al. FIGO staging for Gestational Trophoblastic Neoplasia. International Journal of Gynaecology and Obstetrics 2002; 77: 285-287.
3. Kohorn EI. The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: Description and critical assessment. International Journal of Gynecological Cancer 2001; 11: 73-77.
4. Berkowitz RS & Goldstein DP. Management of molar pregnancy and gestational trophoblastic tumors. In Knapp RC & Berkowitz RS (eds) Gynecological Oncology, 328. New York: McGraw-Hill, 1993, pp 328.
5. Berkowitz RS & Goldstein DP. Gestational trophoblastic diseases. In: Hoskins WJ, Rerez AP & Young RC (eds). Principles and Practice of Gynecologic Oncology. Philadelphia: Williams and Wilkins, 2000, pp 1117-1137.
6. Hancock BW & Tidy JA. Clinical management of persistent low level hCG elevation. Trophoblast Disease Update 2002; 4: 5. Retrieved from the International Society for the Study of Trophoblastic Disease website: http://www.isstd.org/journal/new_page_5.htm.
7. Cole LA. False positive or phantom hCG result: A serious problem. Clinical Laboratory International 2001; 25: 9-14.
8. Bagshawe KD & Harland S. Immunodiagnosis and monitoring of gonadotrophin-producing metastases in the central nervous system. Cancer 1976; 38: 112.
9. Berkowitz RS, Osathanondh R, Goldstein et al. Cerebrospinal fluid human chorionic gonadotrophin levels in normal pregnancy and choriocarcinoma. Surgery Gynecology and Obstetrics 1981; 153: 687-689.
10. Ngan HYS, Au VWK, Cheng DKL et al. Clinical outcome of micrometastasis in the lung in Stage IA persistent gestational trophoblastic disease. Gynecologic Oncology 1998; 70: 192-194.
11. Nevin J, Silcocks P, Hancock BW et al. Guidelines for the stratification of patients recruited to trials of therapy for low-risk gestational trophoblastic tumor. Gynecology Oncology 2000; 78: 92-96.
12. Anderson, et al. A. M. A. Arch. Surgery 1954; 68: 829-837.
13. Bagshawe KD. Risks and prognostic factors in trophoblastic neoplasia. Cancer 1976; 38: 1373-1385.
14. Wong LC, Choo YC & Ma HK. Primary oral etoposide therapy in gestational trophoblastic disease, an update. Cancer 1986; 58: 14-17.
15. Sung HC, Wu PC & Yang HY. Re-evaluation of 5-fluorouracil as a single therapeutic agent for gestational trophoblastic neoplasms. American Journal of Obstetrics and Gynecology 1984; 150: 69-75.
16. Wong LC, Ngan HYS, Cheng DKL & Ng TY. Methotrexate infusion in low-risk gestational trophoblastic disease. American Journal of Obstetrics and Gynecology 2000; 183: 1579-1582.
17. Wong LC, Choo YK & Ma HK. Etoposide, methotrexate and bleomycin in drug-resistant gestational trophoblastic disease. Gynecologic Oncology 1986; 24: 51-57.
18. Bower M, Newlands ES, Holden L et al. EMA/CO (etoposide, methotrexate, actinomycin-D, cyclophosphamide, vincristine) for high risk gestational trophoblastic tumours - Results from a cohort of 272 patients. Journal of Clinical Oncology 1997; 15: 2636-2643.
19. Rustin GJS, Newlands ES, Lutz JM et al. Combination but not single-agent methotrexate chemotherapy for gestational trophoblastic tumors increases the incidence of second tumors. Journal of Clinical Oncology 1996; 14: 2769-2773.
20. Cole LA (ed.) When is it safe to get pregnant after having complete or partial mole, or persistent trophoblastic disease. Trophoblast Disease Update, 2.; 1998. Retrieved 24/1/03 from the International Society for the Study of Trophoblastic Diseases website: http:/www.isstd.org.journal/vol2.html.
21. Woolas RP, Bower M, Newlands ES et al. Influence of chemotherapy for gestational trophoblastic disease on subsequent pregnancy outcome. British Journal of Obstetrics and Gynaecology 1998; 105: 1032-1035.